Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05802615 · ClinicalTrials.gov registry record · NA

Protective Assets Reinforced With Integrated Care and TechnologY (PARITY) Feasibility Trial

A NA study of Blood Pressure and Maternal Health, sponsored by University of Nebraska.

Completed
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT05802615 is a NA study of Blood Pressure and Maternal Health that has completed, run by University of Nebraska. The registered enrollment target is 60 participants, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05802615, a NA study of Blood Pressure and Maternal Health, has completed, sponsored by University of Nebraska.

COMPLETED
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

This study will determine the feasibility and acceptability of the Protective Assets Reinforced with Integrated care and TechnologY (PARITY) program, to test the clinical, behavioral, and strength building efficacy of the PARITY program and explore how it achieves its outcomes in pregnant Black women. PARITY is a program that provides community-based doula support, community resources, and a mobile technology platform that reinforces individual strengths (referred to as protective assets) through positive messaging and by promoting wellness.

Interventions

  • OTHER Usual Care
  • BEHAVIORAL PARITY

Study Locations (1)

Nebraska

  • University of Nebraska Medical Center - Omaha

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2023-04-06
Est. Completion 2025-08-06
Phase NA

Sponsor

University of Nebraska

407 total trials

What the Registry Record Tells You About NCT05802615

The ClinicalTrials.gov registry entry for NCT05802615 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 286-participant average among 101 other Blood Pressure trials with a reported enrollment target (79% lower). The listed sponsor is University of Nebraska, which has 407 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Blood Pressure appearing as the primary indexed condition, and to 2 interventions - of which Usual Care is the first listed.

NCT05802615 reports 1 study location spanning 1 distinct geographic area - top geographies include Nebraska.

Frequently Asked Questions

What is clinical trial NCT05802615 about?

NCT05802615 is a clinical study titled "Protective Assets Reinforced With Integrated Care and TechnologY (PARITY) Feasibility Trial". This study will determine the feasibility and acceptability of the Protective Assets Reinforced with Integrated care and TechnologY (PARITY) program, to test the clinical, behavioral, and strength building efficacy of the PARITY program and explore how it achieves its outcomes in pregnant Black wome...

What is the current status of trial NCT05802615?

This trial is currently completed. It is a NA study. The enrollment target is 60 participants. The study started on 2023-04-06. Estimated completion is 2025-08-06.

What conditions does trial NCT05802615 study?

This clinical trial studies the following conditions: Blood Pressure, Maternal Health.

What interventions are being tested in trial NCT05802615?

The interventions under investigation include: Usual Care (OTHER), PARITY (BEHAVIORAL).

Who is sponsoring clinical trial NCT05802615?

This trial is sponsored by University of Nebraska, which has 407 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05802615 being conducted?

This trial has 1 study location across Nebraska. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Blood Pressure

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.